IRIS
MICIACCIA, MORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.625
AS - Asia 1.340
EU - Europa 1.040
SA - Sud America 302
AF - Africa 52
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.522
IT - Italia 554
SG - Singapore 523
CN - Cina 262
BR - Brasile 228
HK - Hong Kong 176
RU - Federazione Russa 93
VN - Vietnam 89
CA - Canada 78
DE - Germania 77
GB - Regno Unito 55
SE - Svezia 52
IN - India 51
BD - Bangladesh 48
FR - Francia 39
JP - Giappone 33
NL - Olanda 28
AU - Australia 26
CH - Svizzera 26
FI - Finlandia 24
ID - Indonesia 24
TR - Turchia 22
AR - Argentina 19
EC - Ecuador 18
ES - Italia 16
IQ - Iraq 13
KR - Corea 13
MX - Messico 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
PL - Polonia 12
SA - Arabia Saudita 12
CO - Colombia 11
BE - Belgio 10
PH - Filippine 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
CL - Cile 8
PK - Pakistan 8
AT - Austria 7
IR - Iran 7
LT - Lituania 7
VE - Venezuela 6
HU - Ungheria 5
IE - Irlanda 5
IL - Israele 5
PY - Paraguay 5
TW - Taiwan 5
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
MD - Moldavia 2
SC - Seychelles 2
TN - Tunisia 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GI - Gibilterra 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
ML - Mali 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.387
Salva come PNG Salva come JPEG
Città #
Singapore 265
Ashburn 244
San Jose 220
Hong Kong 169
Beijing 95
Milan 80
Bari 73
Dallas 60
Sannicandro di Bari 57
New York 51
Columbus 49
Chandler 48
Los Angeles 43
Nyköping 39
Fairfield 37
Rome 37
Ho Chi Minh City 36
Council Bluffs 34
Vancouver 29
Helsinki 24
São Paulo 23
Tokyo 22
Cambridge 21
Santa Clara 21
Boardman 20
Falkenstein 20
Munich 18
Frankfurt am Main 17
Houston 17
Lauterbourg 17
San Francisco 17
Toronto 17
Woodbridge 16
Bern 14
Jakarta 14
Seattle 14
Catania 13
Denver 13
London 13
Taranto 13
Abidjan 12
Atlanta 12
Buffalo 12
Hanoi 12
Montreal 11
Brussels 10
Naples 10
Tashkent 10
Waltham 10
Warsaw 10
Wilmington 10
Bitonto 9
New Delhi 9
Nuremberg 9
Palermo 9
Brno 8
Chennai 8
Orem 8
Phoenix 8
Santiago 8
Shanghai 8
West Lafayette 8
Ann Arbor 7
Belo Horizonte 7
Brooklyn 7
Burlington 7
Chuncheon 7
City of London 7
Florence 7
Guayaquil 7
Johannesburg 7
Palo Alto 7
Philadelphia 7
Brisbane 6
Chicago 6
Dalmine 6
Düsseldorf 6
Jeddah 6
Lawrence 6
Lecce 6
Mersin 6
Mexico City 6
Mumbai 6
Perth 6
Prineville 6
Stockholm 6
Sydney 6
Turin 6
Bologna 5
Boston 5
Dearborn 5
Forest City 5
Madrid 5
Medellín 5
Moscow 5
Petaluma 5
Quito 5
Riyadh 5
Roxbury 5
Warrington 5
Totale 2.468
Salva come PNG Salva come JPEG
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 253
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 189
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 176
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 159
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior 138
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 134
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 127
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 124
DECONSTRUCTING ONC201 TO DESIGN NEW MITOCHONDRIAL ClpP ACTIVATORS FOR PEDIATRIC H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 121
STRUCTURAL EVOLUTION OF ONC201-DERIVED COMPOUNDS TARGETING THE MITOCHONDRIAL PROTEASE CLPP FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA H3K27-ALTERED" 119
Three-dimensional structure of human cyclooxygenase (hCOX)-1 119
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery 117
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 108
Three-dimensional structure of human cyclooxygenase (hCOX)-1 108
Novel hClpP protease activators with potential anticancer activity in DIPG patients 103
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 100
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 99
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 97
Ovine COX-1 Isoenzyme Bio-production 95
TARGETING HUMAN MITOCHONDRIAL ClpP AS A NOVEL THERAPEUTIC APPROACH TO H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 94
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 93
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 91
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 91
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges 90
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 89
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 88
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 87
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 86
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 82
Structure-activity relationships of piperazine-2-one derivatives as novel human ClpP activators 81
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug. 79
Inside circular economy challenges: “green” application to valorise olive mill wastewater 72
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 70
Mitochondrial Protease ClpP: Cancer Marker and Drug Target 68
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy 67
The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 cells 66
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 66
Design and synthesis of new [4,5-b] and [4,5-c] imidazopyridines as potential fluorophores/inhibitors for Human Cyclooxygenase-1. 66
KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation 64
Structural simplification of imipridones to speed up the knowledge on the nature of the interactions with the human ClpP, a mitochondrial protease strictly linked to DIPG 63
Can Focused Ultrasound Overcome the Failure of Chemotherapy in Treating Pediatric Diffuse Intrinsic Pontine Glioma Due to a Blood–Brain Barrier Obstacle? 62
Potassium channels and TRPV1 modulators on SU-DIPG-36 and SU-DIPG-50 cells: in vitro effects and channel currents characterization 57
Exosomes in Ovarian Cancer: Towards Precision Oncology 52
Harmaline as novel mitochondrial human ClpP activator for the treatment of pediatric DIPG 51
Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake 45
ONC201-derived Tetrahydropyridopyrimidindiones as powerful ClpP protease activators to tackle diffuse midline glioma 44
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 41
Triazole-benzodiazepine derivatives: One-pot synthesis, characterization, hirshfeld surface analysis, and computational insights into anticancer potential as KIF11 inhibitors 25
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive 24
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood–Brain Barrier Permeability and Neuroprotective Chelation Therapy 23
Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes 9
Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines 7
TARGETING HUMAN MITOCHONDRIAL ClpP: A THRILLING CHALLENGE FOR NEW THERAPEUTIC STRATEGIES IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 6
Totale 4.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202275 10 6 1 2 2 5 2 14 3 8 9 13
2022/2023152 8 19 17 6 18 21 4 27 19 4 6 3
2023/2024295 4 14 14 24 26 18 16 7 95 35 16 26
2024/2025924 41 14 40 35 68 78 150 86 47 60 88 217
2025/20262.723 274 105 183 263 333 154 299 126 363 273 164 186
2026/2027228 228 0 0 0 0 0 0 0 0 0 0 0
Totale 4.585